🇺🇸 FDA
Patent

US 11174267

Spiroindolinones and therapeutic uses thereof

granted A61KA61K31/404A61K31/4174

Quick answer

US patent 11174267 (Spiroindolinones and therapeutic uses thereof) held by The Regents of the University of California expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/404, A61K31/4174, A61K31/4196, A61K31/422